AnteoTech Limited (ADO.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 4.07 Million AUD | 36.49% |
| 2023 | 2.98 Million AUD | 2.65% |
| 2022 | 2.9 Million AUD | 13.56% |
| 2021 | 2.56 Million AUD | 266.1% |
| 2020 | 699.62 Thousand AUD | 31.37% |
| 2019 | 532.55 Thousand AUD | 13.76% |
| 2018 | 468.13 Thousand AUD | -98.79% |
| 2017 | 38.71 Million AUD | 0.18% |
| 2016 | 38.64 Million AUD | 5483.63% |
| 2015 | 692.04 Thousand AUD | 22.36% |
| 2014 | 565.6 Thousand AUD | 13.21% |
| 2013 | 499.58 Thousand AUD | 13.84% |
| 2012 | 438.83 Thousand AUD | 11.35% |
| 2011 | 394.09 Thousand AUD | 19.84% |
| 2010 | 328.84 Thousand AUD | 9.79% |
| 2009 | 299.52 Thousand AUD | -35.15% |
| 2008 | 461.88 Thousand AUD | 13.01% |
| 2007 | 408.7 Thousand AUD | 28.99% |
| 2006 | 316.86 Thousand AUD | 54.3% |
| 2005 | 205.35 Thousand AUD | -84.52% |
| 2004 | 1.32 Million AUD | -16.12% |
| 2003 | 1.58 Million AUD | -1.04% |
| 2002 | 1.59 Million AUD | 20.33% |
| 2001 | 1.32 Million AUD | 114.9% |
| 2000 | 618.04 Thousand AUD | 5451.47% |
| 1999 | 11.13 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.64 Million AUD | 0.0% |
| 2024 FY | 4.07 Million AUD | 36.49% |
| 2024 Q4 | 4.07 Million AUD | 0.0% |
| 2023 Q4 | 2.98 Million AUD | 0.0% |
| 2023 Q2 | 2.79 Million AUD | 0.0% |
| 2023 FY | 2.98 Million AUD | 2.65% |
| 2022 FY | 2.9 Million AUD | 13.56% |
| 2022 Q4 | 2.9 Million AUD | 0.0% |
| 2022 Q2 | 2.24 Million AUD | 0.0% |
| 2021 Q2 | 822.75 Thousand AUD | 0.0% |
| 2021 FY | 2.56 Million AUD | 266.1% |
| 2021 Q4 | 2.56 Million AUD | 0.0% |
| 2020 FY | 699.62 Thousand AUD | 31.37% |
| 2020 Q2 | 797.82 Thousand AUD | 0.0% |
| 2020 Q4 | 699.62 Thousand AUD | 0.0% |
| 2019 Q2 | 275.34 Thousand AUD | 0.0% |
| 2019 Q4 | 532.55 Thousand AUD | 0.0% |
| 2019 FY | 532.55 Thousand AUD | 13.76% |
| 2018 Q2 | 552.57 Thousand AUD | 0.0% |
| 2018 FY | 468.13 Thousand AUD | -98.79% |
| 2018 Q4 | 468.13 Thousand AUD | 0.0% |
| 2017 Q4 | 38.71 Million AUD | 0.0% |
| 2017 Q2 | 19.31 Million AUD | 0.0% |
| 2017 FY | 38.71 Million AUD | 0.18% |
| 2016 Q2 | 1.07 Million AUD | 0.0% |
| 2016 FY | 38.64 Million AUD | 5483.63% |
| 2016 Q4 | 38.64 Million AUD | 0.0% |
| 2015 FY | 692.04 Thousand AUD | 22.36% |
| 2015 Q2 | 582.03 Thousand AUD | 0.0% |
| 2015 Q4 | 692.04 Thousand AUD | 0.0% |
| 2014 Q2 | 574.25 Thousand AUD | 0.0% |
| 2014 FY | 565.6 Thousand AUD | 13.21% |
| 2014 Q4 | 565.6 Thousand AUD | 0.0% |
| 2013 Q3 | 439.26 Thousand AUD | 14.96% |
| 2013 Q2 | 382.08 Thousand AUD | 0.0% |
| 2013 Q1 | 382.08 Thousand AUD | -12.93% |
| 2013 FY | 499.58 Thousand AUD | 13.84% |
| 2013 Q4 | 499.58 Thousand AUD | 13.73% |
| 2012 FY | 438.83 Thousand AUD | 11.35% |
| 2012 Q4 | 438.83 Thousand AUD | 0.0% |
| 2011 FY | 394.09 Thousand AUD | 19.84% |
| 2011 Q4 | 394.09 Thousand AUD | 0.0% |
| 2010 Q4 | 328.84 Thousand AUD | 0.0% |
| 2010 FY | 328.84 Thousand AUD | 9.79% |
| 2009 FY | 299.52 Thousand AUD | -35.15% |
| 2009 Q4 | 299.52 Thousand AUD | 0.0% |
| 2008 FY | 461.88 Thousand AUD | 13.01% |
| 2008 Q4 | 461.88 Thousand AUD | 0.0% |
| 2007 Q4 | 408.7 Thousand AUD | 0.0% |
| 2007 FY | 408.7 Thousand AUD | 28.99% |
| 2006 FY | 316.86 Thousand AUD | 54.3% |
| 2006 Q4 | 316.86 Thousand AUD | 0.0% |
| 2005 Q4 | 205.35 Thousand AUD | 0.0% |
| 2005 FY | 205.35 Thousand AUD | -84.52% |
| 2004 Q4 | 1.32 Million AUD | 0.0% |
| 2004 FY | 1.32 Million AUD | -16.12% |
| 2003 FY | 1.58 Million AUD | -1.04% |
| 2003 Q4 | 1.58 Million AUD | 0.0% |
| 2002 FY | 1.59 Million AUD | 20.33% |
| 2002 Q4 | 1.59 Million AUD | 0.0% |
| 2001 Q4 | 1.32 Million AUD | 0.0% |
| 2001 FY | 1.32 Million AUD | 114.9% |
| 2000 FY | 618.04 Thousand AUD | 5451.47% |
| 1999 FY | 11.13 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | -15.037% |
| Acrux Limited | 5.68 Million AUD | 28.341% |
| Race Oncology Limited | 1.91 Million AUD | -112.649% |
| Biome Australia Limited | 5.37 Million AUD | 24.157% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -9.195% |
| BTC Health Limited | 203.94 Thousand AUD | -1898.184% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 68.17% |
| CSL Limited | 27.88 Billion AUD | 99.985% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 51.088% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 85.504% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 3.639% |
| Hexima Limited | 248.67 Thousand AUD | -1538.821% |
| Immutep Limited | 10.97 Million AUD | 62.883% |
| Memphasys Limited | 5.59 Million AUD | 27.129% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 90.47% |
| Noxopharm Limited | 1.28 Million AUD | -216.251% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -75.237% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 90.88% |
| Starpharma Holdings Limited | 8.69 Million AUD | 53.147% |
| Tissue Repair Ltd | 1.35 Million AUD | -201.669% |
| Biotron Limited | 737.5 Thousand AUD | -452.571% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 24.89% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -1228.099% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -1006.066% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 56.445% |
| Patrys Limited | 691.36 Thousand AUD | -489.451% |
| Orthocell Limited | 22.08 Million AUD | 81.545% |
| Imugene Limited | 33.14 Million AUD | 87.704% |
| PYC Therapeutics Limited | 10.18 Million AUD | 59.984% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -150.642% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -247.999% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -98.152% |
| Nanollose Limited | 465.64 Thousand AUD | -775.189% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -844.155% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -4656.203% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -18.923% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -289.744% |
| Nyrada Inc. | 855.63 Thousand AUD | -376.286% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 98.366% |
| Dimerix Limited | 13.89 Million AUD | 70.667% |
| PharmAust Limited | 896.6 Thousand AUD | -354.52% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -13.696% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 74.359% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -332.829% |
| Actinogen Medical Limited | 1.61 Million AUD | -152.28% |
| Immuron Limited | 2.84 Million AUD | -43.468% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -67.933% |